Chronic Disease
Our work in Chronic Disease
-
Schaeffer Center Economic Modeling Contributes to National Academy Report on Diversity in Clinical Trials
Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades.
Categorized in -
The Relationship Between Multimorbidity and Types of Chronic Diseases and Self-Rated Memory
This study explores the impact of multimorbidity and types of chronic diseases on self-rated memory in older adults in the United States.
Categorized in -
Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma
Researchers aimed to quantify the value of reducing chimeric antigen receptor T-cell (CAR-T) treatment wait times on patients with refractory and relapsed aggressive blood cancer who can newly gain access to treatment or access treatment earlier in their disease course.
Categorized in -
The Price of Insulin, Explained
This animation explains research by Schaeffer Center experts that offers one of the most comprehensive looks at the insulin distribution chain and shows which players are profiting, and by how much, from selling insulin.
Categorized in -
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.
Categorized in -
Middlemen, Not Drug Companies, Are Pushing Up Insulin Prices, and Congress Doesn’t Have the Right Plan to Fight Back
Congress should take advantage of the current political climate and start reining in the intermediaries in the drug distribution system.
Categorized in -
Patient and Physician Perspectives On Engaging in Palliative and Healthcare Trials: A Qualitative Descriptive Study
Researchers are encountering increasing challenges in recruiting participants for palliative and healthcare research. This paper aims to understand challenges to and methods for engaging physicians and seriously ill patients and their caregivers in research studies.
Categorized in -
Early Transplantation Maximizes Survival in Severe Acute-On-Chronic Liver Failure: Results of a Markov Decision Process Model
The researchers create a Markov decision process model to maximize overall survival among patients listed for liver transplantation with grade three acute-on-chronic liver failure (ACLF-3) within the first 7 days of listing
Categorized in -
After Their Initial Diagnosis, Many Adult COVID-19 Patients Continue Seeking Medical Care for up to Six Months or More
Analyzing claims data, does COVID-19 related healthcare utilization persist in for 180 days or more, also known as long COVID, after their initial diagnosis?
Categorized in -
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
Policy makers have suggested increasing peritoneal dialysis (PD) would improve end-stage kidney disease (ESKD) outcomes and reduce Medicare spending compared with hemodialysis (HD). We compared mortality, hospitalizations, and Medicare spending between PD and HD among uninsured adults with incident ESKD.
Categorized in